218 related articles for article (PubMed ID: 22493296)
1. Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis.
Zaitsev S; Kowalska MA; Neyman M; Carnemolla R; Tliba S; Ding BS; Stonestrom A; Spitzer D; Atkinson JP; Poncz M; Cines DB; Esmon CT; Muzykantov VR
Blood; 2012 May; 119(20):4779-85. PubMed ID: 22493296
[TBL] [Abstract][Full Text] [Related]
2. Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury.
Carnemolla R; Villa CH; Greineder CF; Zaitsev S; Patel KR; Kowalska MA; Atochin DN; Cines DB; Siegel DL; Esmon CT; Muzykantov VR
FASEB J; 2017 Feb; 31(2):761-770. PubMed ID: 27836986
[TBL] [Abstract][Full Text] [Related]
3. Vascular immunotargeting to endothelial determinant ICAM-1 enables optimal partnering of recombinant scFv-thrombomodulin fusion with endogenous cofactor.
Greineder CF; Chacko AM; Zaytsev S; Zern BJ; Carnemolla R; Hood ED; Han J; Ding BS; Esmon CT; Muzykantov VR
PLoS One; 2013; 8(11):e80110. PubMed ID: 24244621
[TBL] [Abstract][Full Text] [Related]
4. Platelet endothelial cell adhesion molecule targeted oxidant-resistant mutant thrombomodulin fusion protein with enhanced potency in vitro and in vivo.
Carnemolla R; Greineder CF; Chacko AM; Patel KR; Ding BS; Zaitsev S; Esmon CT; Muzykantov VR
J Pharmacol Exp Ther; 2013 Nov; 347(2):339-45. PubMed ID: 23965383
[TBL] [Abstract][Full Text] [Related]
5. Biocompatible coupling of therapeutic fusion proteins to human erythrocytes.
Villa CH; Pan DC; Johnston IH; Greineder CF; Walsh LR; Hood ED; Cines DB; Poncz M; Siegel DL; Muzykantov VR
Blood Adv; 2018 Feb; 2(3):165-176. PubMed ID: 29365311
[TBL] [Abstract][Full Text] [Related]
6. Anchoring fusion thrombomodulin to the endothelial lumen protects against injury-induced lung thrombosis and inflammation.
Ding BS; Hong N; Christofidou-Solomidou M; Gottstein C; Albelda SM; Cines DB; Fisher AB; Muzykantov VR
Am J Respir Crit Care Med; 2009 Aug; 180(3):247-56. PubMed ID: 19342415
[TBL] [Abstract][Full Text] [Related]
7. Soluble thrombomodulin is antithrombotic in the presence of neutralising antibodies to protein C and reduces circulating activated protein C levels in primates.
Tanaka KA; Fernández JA; Marzec UM; Kelly AB; Mohri M; Griffin JH; Hanson SR; Gruber A
Br J Haematol; 2006 Jan; 132(2):197-203. PubMed ID: 16398653
[TBL] [Abstract][Full Text] [Related]
8. Probing the activation of protein C by the thrombin-thrombomodulin complex using structural analysis, site-directed mutagenesis, and computer modeling.
Knobe KE; Berntsdotter A; Shen L; Morser J; Dahlbäck B; Villoutreix BO
Proteins; 1999 May; 35(2):218-34. PubMed ID: 10223294
[TBL] [Abstract][Full Text] [Related]
9. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation.
Ammollo CT; Semeraro F; Xu J; Esmon NL; Esmon CT
J Thromb Haemost; 2011 Sep; 9(9):1795-803. PubMed ID: 21711444
[TBL] [Abstract][Full Text] [Related]
10. Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation.
Zaitsev S; Spitzer D; Murciano JC; Ding BS; Tliba S; Kowalska MA; Marcos-Contreras OA; Kuo A; Stepanova V; Atkinson JP; Poncz M; Cines DB; Muzykantov VR
Blood; 2010 Jun; 115(25):5241-8. PubMed ID: 20410503
[TBL] [Abstract][Full Text] [Related]
11. Thrombin cleaves recombinant soluble thrombomodulin into a lectin-like domain fragment and a fragment with protein C-activating cofactor activity.
Yokoyama H; Tateishi K; Baba Y; Kobayashi A; Hashimoto M; Fukuda S; Yamao H; Maruyama T; Nakata M; Matsushita M
Biosci Trends; 2022 Dec; 16(6):444-446. PubMed ID: 36450579
[TBL] [Abstract][Full Text] [Related]
12. Evidence that the protein C activation pathway amplifies the inhibition of thrombin generation by recombinant human thrombomodulin in plasma.
Ohishi R; Watanabe N; Aritomi M; Gomi K; Kiyota T; Yamamoto S; Ishida T; Maruyama I
Thromb Haemost; 1993 Sep; 70(3):423-6. PubMed ID: 8259542
[TBL] [Abstract][Full Text] [Related]
13. Amplified anticoagulant activity of tissue factor-targeted thrombomodulin: in-vivo validation of a tissue factor-neutralizing antibody fused to soluble thrombomodulin.
Wang YX; Wu C; Vincelette J; Martin-McNulty B; Alexander S; Larsen B; Light DR; McLean K
Thromb Haemost; 2006 Sep; 96(3):317-24. PubMed ID: 16953273
[TBL] [Abstract][Full Text] [Related]
14. Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin.
Mosnier LO
J Biol Chem; 2011 Jan; 286(1):502-10. PubMed ID: 21041299
[TBL] [Abstract][Full Text] [Related]
15. Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injurywithout bleeding complications.
Song Y; Bienvenu LA; Bongcaron V; Prijaya SA; Maluenda AC; Walsh APG; McFayden JD; Pietersz GA; Peter K; Wang X
Theranostics; 2024; 14(8):3267-3281. PubMed ID: 38855181
[No Abstract] [Full Text] [Related]
16. Thrombomodulin alfa attenuates the procoagulant effect and cytotoxicity of extracellular histones through the promotion of protein C activation.
Osada K; Minami T; Arioka T; Sakai T; Tawara S; Kawasaki K; Fareed J; Matsuzaki O
Thromb Res; 2017 Dec; 160():51-57. PubMed ID: 29101790
[TBL] [Abstract][Full Text] [Related]
17. Targeted antithrombotic protein micelles.
Kim W; Haller C; Dai E; Wang X; Hagemeyer CE; Liu DR; Peter K; Chaikof EL
Angew Chem Int Ed Engl; 2015 Jan; 54(5):1461-5. PubMed ID: 25504546
[TBL] [Abstract][Full Text] [Related]
18. Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis.
Zaitsev S; Spitzer D; Murciano JC; Ding BS; Tliba S; Kowalska MA; Bdeir K; Kuo A; Stepanova V; Atkinson JP; Poncz M; Cines DB; Muzykantov VR
J Pharmacol Exp Ther; 2010 Mar; 332(3):1022-31. PubMed ID: 19952305
[TBL] [Abstract][Full Text] [Related]
19. Recombinant and chemo-/bio-orthogonal synthesis of liposomal thrombomodulin and its antithrombotic activity.
Wang L; Jiang R; Liu Y; Cheng M; Wu Q; Sun XL
J Biosci Bioeng; 2017 Oct; 124(4):445-451. PubMed ID: 28694021
[TBL] [Abstract][Full Text] [Related]
20. Thrombomodulin accelerates activated protein C production and inhibits thrombin generation in the plasma of disseminated intravascular coagulation patients.
Wada H; Sakakura M; Kushiya F; Nisikawa M; Onishi K; Nakatani K; Shiku H; Nobori T
Blood Coagul Fibrinolysis; 2005 Jan; 16(1):17-24. PubMed ID: 15650541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
